Goldman Sachs Downgrades Laboratory Corporation of America (LH) to Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- AMD shares fall amid AI chip sector selloff
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- JetBlue shares fall amid American results, fuel cost concerns
Laboratory Corporation of America (LH) PT Lowered to $165 at Barclays Following 4Q Guidance Reduction
December 3, 2018 7:39 AM ESTBarclays analyst Jack Meehan lowered the price target on Laboratory Corporation of America (NYSE: LH) to $165.00 (from $205.00) while maintaining a Overweight rating following the company's reduction in 4Q guidance.
The magnitude of the reduction so shortly after the company reduced guidance with 3Q... More
Laboratory Corporation of America (LH) PT Lowered to $155 at Deutsche Bank
November 30, 2018 12:12 PM ESTDeutsche Bank analyst Dan Leonard lowered the price target on Laboratory Corporation of America (NYSE: LH) to $155.00 (from $165.00) while maintaining a Hold rating.
... More


